Related content

Normalisation of serum cholestanol concentration in a patient with cerebrotendinous xanthomatosis by combined treatment with chenodeoxycholic acid, simvastatin and LDH apheresis

By Dotti* M.   Lütjohann* D.   Bergmann K.   Federico A.  

Neurological Sciences, Vol. 25, Iss. 4, 2004-10 ,pp. : 185-191

Springer Publishing Company

Access to resources Recommend Favorite

Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis

By Verrips A.   Lycklama à Nijeholt G. J.   Barkhof F.   Van Engelen B. G. M.   Wesseling P.   Luyten J. A. F. M.   Wevers R. A.   Stam J.   Wokke J. H. J.   van den Heuvel L. P. W. J.   Keyser A.  

Brain, Vol. 122, Iss. 8, 1999-08 ,pp. : 1589-1595

Oxford University Press

Access to resources Recommend Favorite

Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis

By de Stefano N.  

Brain, Vol. 124, Iss. 1, 2001-01 ,pp. : 121-131

Oxford University Press

Access to resources Recommend Favorite

Spinal phenotype of cerebrotendinous xanthomatosis

By Bartholdi D.   Zumsteg D.   Verrips A.   Wevers R.   Sistermans E.   Hess K.   Jung H.  

Journal of Neurology, Vol. 251, Iss. 1, 2004-01 ,pp. : 105-107

Springer Publishing Company

Access to resources Recommend Favorite

Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis

By Mignarri A.   Rossi S.   Ballerini M.   Gallus G.   Puppo M.   Galluzzi P.   Federico A.   Dotti M.  

Journal of Neurology, Vol. 258, Iss. 5, 2011-05 ,pp. : 783-790

Springer Publishing Company

Access to resources Recommend Favorite